These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36919284)

  • 41. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.
    Rohatgi S; Gohil S; Kuniholm MH; Schultz H; Dufaud C; Armour KL; Badri S; Mailliard RB; Pirofski LA
    mBio; 2013 Aug; 4(5):e00573-13. PubMed ID: 23982074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis.
    Sfar I; Dhaouadi T; Habibi I; Abdelmoula L; Makhlouf M; Ben Romdhane T; Jendoubi-Ayed S; Aouadi H; Ben Abdallah T; Ayed K; Zouari R; Lakhoua-Gorgi Y
    Arch Inst Pasteur Tunis; 2009; 86(1-4):51-62. PubMed ID: 20707220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.
    Adu B; Dodoo D; Adukpo S; Hedley PL; Arthur FK; Gerds TA; Larsen SO; Christiansen M; Theisen M
    PLoS One; 2012; 7(9):e46197. PubMed ID: 23049979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.
    Quartuccio L; Fabris M; Pontarini E; Salvin S; Zabotti A; Benucci M; Manfredi M; Biasi D; Ravagnani V; Atzeni F; Sarzi-Puttini P; Morassi P; Fischetti F; Tomietto P; Bazzichi L; Saracco M; Pellerito R; Cimmino M; Schiavon F; Carraro V; Semeraro A; Caporali R; Cavagna L; Bortolotti R; Paolazzi G; Govoni M; Bombardieri S; De Vita S
    Ann Rheum Dis; 2014 Apr; 73(4):716-21. PubMed ID: 23505228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association study of copy number variants in FCGR3A and FCGR3B gene with risk of ankylosing spondylitis in a Chinese population.
    Wang L; Yang X; Cai G; Xin L; Xia Q; Zhang X; Li X; Wang M; Wang K; Xia G; Xu S; Xu J; Zou Y; Pan F
    Rheumatol Int; 2016 Mar; 36(3):437-42. PubMed ID: 26494566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Switching from an anti-TNF monoclonal antibody to soluble TNF-receptor yields better results than vice versa: An observational retrospective study of 72 rheumatoid arthritis switchers.
    Lequerré T; Farran É; Ménard JF; Kozyreff-Meurice M; Vandhuick T; Tharasse C; Pouplin S; Daragon A; Le Loët X; Varin R; Vittecoq O
    Joint Bone Spine; 2015 Oct; 82(5):330-7. PubMed ID: 25864942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.
    Robinson JI; Md Yusof MY; Davies V; Wild D; Morgan M; Taylor JC; El-Sherbiny Y; Morris DL; Liu L; Rawstron AC; Buch MH; Plant D; Cordell HJ; Isaacs JD; Bruce IN; Emery P; Barton A; Vyse TJ; Barrett JH; Vital EM; Morgan AW; ;
    EBioMedicine; 2022 Dec; 86():104343. PubMed ID: 36371989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.
    Breunis WB; van Mirre E; Geissler J; Laddach N; Wolbink G; van der Schoot E; de Haas M; de Boer M; Roos D; Kuijpers TW
    Hum Mutat; 2009 May; 30(5):E640-50. PubMed ID: 19309690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.
    Montes A; Perez-Pampin E; Narváez J; Cañete JD; Navarro-Sarabia F; Moreira V; Fernández-Nebro A; Del Carmen Ordóñez M; de la Serna AR; Magallares B; Vasilopoulos Y; Sarafidou T; Caliz R; Ferrer MA; Joven B; Carreira P; Gómez-Reino JJ; Gonzalez A
    Pharmacogenet Genomics; 2014 May; 24(5):238-45. PubMed ID: 24667440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
    Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO
    Autoimmun Rev; 2020 May; 19(5):102509. PubMed ID: 32173513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies.
    Matsumoto I; Zhang H; Muraki Y; Hayashi T; Yasukochi T; Kori Y; Goto D; Ito S; Tsutsumi A; Sumida T
    Arthritis Res Ther; 2005; 7(6):R1183-8. PubMed ID: 16277670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
    Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
    Front Immunol; 2019; 10():1208. PubMed ID: 31249568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis.
    Marques RB; Thabet MM; White SJ; Houwing-Duistermaat JJ; Bakker AM; Hendriks GJ; Zhernakova A; Huizinga TW; van der Helm-van Mil AH; Toes RE
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.
    Wahrmann M; Döhler B; Arnold ML; Scherer S; Mayer KA; Haindl S; Haslacher H; Böhmig GA; Süsal C
    Front Immunol; 2021; 12():724331. PubMed ID: 34497614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive Assessment of the Association between FCGRs polymorphisms and the risk of systemic lupus erythematosus: Evidence from a Meta-Analysis.
    Zhu XW; Wang Y; Wei YH; Zhao PP; Wang XB; Rong JJ; Zhong WY; Zhang XW; Wang L; Zheng HF
    Sci Rep; 2016 Aug; 6():31617. PubMed ID: 27538381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.
    Chen JY; Wang CM; Wu JM; Ho HH; Luo SF
    Clin Exp Immunol; 2006 Apr; 144(1):10-6. PubMed ID: 16542359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-nucleotide polymorphisms and copy number variations of the
    Moriya H; Saito K; Helsby N; Hayashi N; Sugino S; Yamakage M; Sawaguchi T; Takasaki M; Takahashi M; Kurosawa N
    Biomed Rep; 2014 Mar; 2(2):265-269. PubMed ID: 24649108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.
    Kjersem JB; Skovlund E; Ikdahl T; Guren T; Kersten C; Dalsgaard AM; Yilmaz MK; Fokstuen T; Tveit KM; Kure EH
    BMC Cancer; 2014 May; 14():340. PubMed ID: 24884501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.